|
|
|
|
|
|
|
23.07.26 - 02:39
|
AI Is Quietly Transforming Healthcare And Might Just Save Your Life (ZeroHedge)
|
|
|
AI Is Quietly Transforming Healthcare And Might Just Save Your Life
Amid the broader debate over artificial intelligence's economic disruptions, the healthcare sector is quietly demonstrating some of the technology's most concrete applications. Rather than the job losses feared in other industries, hospitals report AI augmenting physicians, streamlining routine tasks and accelerating innovation in ways that could improve outcomes while controlling costs.
At the Mayo Clinic in Rochester, Minnesota, roughly 150 AI models are now in use. A tool called Record Time helps internists distill hundreds of pages of external medical records into searchable summaries, saving five to 30 minutes per patient, according to CNN.
"AI can step in and do a lot of the tedious work that very specialized doctors or medical professionals do to speed up that process - get to more accurate diagnoses, faster so you can treat more people," Jason Droege, CEO of Scale AI, said.
Mayo is also testing AI for early pancreati...
|
|
|
|
|
22.07.26 - 23:12
|
Molina Healthcare Inc Profit Falls In Q2 (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Molina Healthcare Inc (MOH) revealed earnings for second quarter that Drops, from last yearThe company's earnings came in at $60 million, or $1.19 per share. This compares w......
|
|
|
|
|
22.07.26 - 16:33
|
UBS Warns Trump′s 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners (ZeroHedge)
|
|
|
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US.
"This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote on Truth Social late Tuesday.
He continued, "The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is," adding, "Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America."
Trump's announcement is the latest effort to reshore critical supply chains, and in this case, boost domestic productio...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.07.26 - 07:48
|
Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs (Times of India)
|
|
|
Pharmaceutical stocks faced pressure after US President Trump unveiled a phased tariff plan for imported generic medicines. This plan introduces steep duties on generic drugs after a two-year tariff-free window. Indian drugmakers are reassessing supply chains and investment plans due to potential future impacts. Companies without US manufacturing presence may face significantly altered economics. The announcement shifts focus to encouraging domestic production within the United States....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
